BamSEC and AlphaSense Join Forces
Learn More

Intercept Pharmaceuticals, Inc. – Underwriting Agreements

Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 33 pages Intercept Pharmaceuticals, Inc. Sales Agreement
12/34/56
EX-1.2
from 8-K 39 pages Intercept Pharmaceuticals, Inc. (A Delaware Corporation) 2.00% Convertible Senior Notes Due 2026 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 36 pages Intercept Pharmaceuticals, Inc. (A Delaware Corporation) 2,400,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 35 pages Intercept Pharmaceuticals, Inc. (A Delaware Corporation) 2,343,750 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 48 pages Intercept Pharmaceuticals, Inc. (A Delaware Corporation) $400,000,000 3.25% Convertible Senior Notes Due 2023 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages Intercept Pharmaceuticals, Inc. (A Delaware Corporation) 1,200,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 44 pages Intercept Pharmaceuticals, Inc. (A Delaware Corporation) 1,000,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1
from SC 13D/A ~5 pages Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 44 pages Intercept Pharmaceuticals, Inc. (A Delaware Corporation) 1,000,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1
from SC 13D/A ~5 pages Joint Filing Agreement
12/34/56
EX-1.1
from S-1/A 41 pages Intercept Pharmaceuticals, Inc. (A Delaware Corporation) [ ] Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 38 pages Intercept Pharmaceuticals, Inc. (A Delaware Corporation) Shares of Common Stock Underwriting Agreement
12/34/56
EX-1
from SC 13D ~5 pages Joint Filing Agreement
12/34/56
EX-1.1
from S-1/A 41 pages Intercept Pharmaceuticals, Inc. (A Delaware Corporation) [L] Shares of Common Stock Underwriting Agreement
12/34/56